MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/17425255.2024.2349711

Медицинская библиотека · Expert opinion on drug metabolism & toxicology · 2024

Evaluating the pharmacokinetics of upadacitinib for the treatment of moderate-to-severe Crohn's disease.

Faggiani Ilaria, D'Amico Ferdinando, Bernardi Francesca, Bencardino Sarah, Allocca Mariangela, Furfaro Federica, Parigi Tommaso Lorenzo, Zilli Alessandra, Fiorino Gionata, Peyrin-Biroulet Laurent, Danese Silvio

СтатьяОбзорПеревод пока не подготовлен

Аннотация

INTRODUCTION

Janus kinases (JAK) are enzymes involved in signaling pathways that activate the immune system. Upadacitinib, an oral small molecule, is the first JAK inhibitor approved by FDA and EMA for the treatment of moderately to severely active Crohn's disease (CD), following successful phase II and III trials. Compared to other JAK inhibitors, upadacitinib has a high selectivity toward JAK1. This characteristic could improve its efficacy and safety.

AREAS COVERED: This review provides an overview of the available knowledge on the pharmacokinetics of upadacitinib as induction and maintenance therapy for CD.

EXPERT OPINION: The approval of newer targeted small molecules drug, including JAK inhibitors, marked a significant advancement in terms of effectiveness. In fact, the oral administration, the rapid absorption, the excellent bioavailability and the short serum time of maximum concentration are some of the advantages compared to biologics. The selective inhibition of JAK1 by upadacitinib allows for high efficacy while maintaining a reliable safety profile.

Для цитирования: Faggiani Ilaria, D'Amico Ferdinando, Bernardi Francesca, Bencardino Sarah, Allocca Mariangela, Furfaro Federica, Parigi Tommaso Lorenzo, Zilli Alessandra, Fiorino Gionata, Peyrin-Biroulet Laurent, Danese Silvio. Evaluating the pharmacokinetics of upadacitinib for the treatment of moderate-to-severe Crohn's disease.. Expert opinion on drug metabolism & toxicology. 2024. DOI: 10.1080/17425255.2024.2349711.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.